Elaine Johanna Limkin

Title: Elaine Johanna Limkin: Innovator in Cancer Imaging Technology

Introduction

Elaine Johanna Limkin is a prominent inventor based in Cachan, France. She has made significant contributions to the field of cancer research through her innovative work in radiomics-based imaging tools. Her inventions aim to enhance the understanding and treatment of cancer, particularly in monitoring tumor-lymphocyte infiltration.

Latest Patents

Elaine Limkin holds a patent for a radiomics-based imaging tool designed to monitor tumor-lymphocyte infiltration and outcomes in cancer patients treated with anti-PD-1/PD-L1 therapies. This invention proposes a biomarker for detecting the presence and density of tumor-infiltrating CD8 T-cells in solid tumors without the need for biopsies. Additionally, it offers a method to assess the immune phenotype of solid tumors, which can be crucial for prognosing survival and treatment efficiency in patients undergoing immunotherapy.

Career Highlights

Throughout her career, Elaine has worked with esteemed institutions such as Université Paris-Saclay and the Institut National de la Santé et de la Recherche Médicale. Her research has focused on integrating advanced imaging techniques with cancer treatment strategies, contributing to the development of more effective therapeutic approaches.

Collaborations

Elaine has collaborated with notable professionals in her field, including Charles Ferte and Eric Deutsch. These partnerships have furthered her research and innovation in cancer imaging technologies.

Conclusion

Elaine Johanna Limkin is a trailblazer in the realm of cancer research, with her innovative patent paving the way for improved patient outcomes. Her work exemplifies the intersection of technology and medicine, showcasing the potential of radiomics in enhancing cancer treatment strategies.